Recent Expansions DiaSorin S.p.A. has expanded its facilities to Shanghai, China, showcasing a commitment to strengthening its presence in the Chinese market. This expansion presents an opportunity for sales development representatives to explore new partnerships and sales channels within the growing Chinese healthcare industry.

Acquisitions and Mergers DiaSorin S.p.A. acquired Luminex Network Intelligence Group, signifying a strategic move to broaden its offerings. Sales development professionals can leverage this acquisition to introduce integrated solutions to a wider customer base, highlighting the synergistic benefits of the combined entities.

Product Launches With the launch of innovative products like the Simplexa C. auris Direct kit and LIAISON Legionella Urinary Antigen Immunodiagnostic Assay, there are opportunities for sales teams to pitch these cutting-edge solutions to meet the evolving needs of healthcare facilities and research institutions. Highlighting the unique features and benefits of these products can drive sales growth.

Exponential Growth Potential Operating within the biotechnology research industry and with a revenue range of $100M - 1B, DiaSorin presents significant growth potential. Sales development representatives can tap into this potential by targeting key markets and developing tailored sales strategies to capture a larger market share, thereby driving revenue growth.

International Presence DiaSorin's international presence, exemplified by the hire of an Area Sales Manager for the Republic of Ireland and Northern Ireland, highlights opportunities for global sales expansion. By leveraging local talent and expertise, sales teams can establish stronger relationships with customers in these regions, fostering long-term partnerships and driving sales growth.